Company Analysis

Dogwood Therapeutics, Inc. (DWTX)

Nasdaq: DWTX · Pharmaceutical Preparations · Alpharetta, GA · filing with the SEC since 2020
Grade4.2
◀ Past 3.5● Present 4.8▶ Future 4.1
6 est.

Filings

214 filings since 2017 beside 117 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 27, 2026.

Filings a yearinsider forms included
45456241435540
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Nov 21, 2025.Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Nov 21, 2024.SEC letters: 4 in the last 36 months, the newest Jan 27, 2026.
Insider forms 117

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 6, 2026 EFFECT Registration effective
Nov 6, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 30, 2026 S-3 Shelf registration
Oct 27, 2026 SCHEDULE 13D/A Activist holder update, amended
Oct 21, 2026 SCHEDULE 13D/A Activist holder update, amended
Oct 19, 2026 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Jun 17, 2026 8-K items 5.03, 5.07, 9.01 Charter, bylaw or fiscal-year change; Shareholder vote · Current report Jun 16, 2026
May 15, 2026 SCHEDULE 13G Large holder notice
May 15, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 27, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 27, 2026 DEF 14A Proxy statement Jun 16, 2026
Apr 17, 2026 PRE 14A Preliminary proxy statement Jun 16, 2026
Mar 26, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 18, 2026 10-K Annual report Dec 31, 2025
Mar 18, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 12, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Mar 11, 2026
Feb 13, 2026 DEF 14A Proxy statement Mar 11, 2026
Jan 29, 2026 EFFECT Registration effective
Jan 27, 2026 CORRESP Reply to the SEC
Jan 27, 2026 UPLOAD SEC comment letter
Jan 23, 2026 PRE 14A Preliminary proxy statement Mar 11, 2026
Jan 20, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jan 15, 2026 S-3 Shelf registration
Jan 13, 2026 8-K items 1.01, 1.02, 3.02, 7.01, 9.01 Major agreement signed; Major agreement ended; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Jan 9, 2026
Jan 13, 2026 424B5 Shelf offering
Jan 8, 2026 S-8 Employee stock plan registration
Nov 28, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report
Nov 28, 2025 424B5 Shelf offering
Nov 25, 2025 SCHEDULE 13D/A Activist holder update, amended
Nov 21, 2025 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report
Nov 7, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 20, 2025 DEF 14A Proxy statement Nov 21, 2025
Oct 16, 2025 S-3/A Shelf registration, amended
Oct 9, 2025 DEFA14A Extra proxy material
40 of 214 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton DWTX · research, not advice